Info

Days after presentation Fig. 1. Kaplan-Meier survival curve of troponin-positive vs troponin-negative patients with PE. cTnT, cardiac troponin T. (Reprinted with permission from ref. 16.)

A Troponin I Troponin T B

A Troponin I Troponin T B

Mortality Complications Recurrence Mortality Complications Recurrence

Fig. 2. Escalation ofin-hospital mortality, complications, and recurrence rates depending on baseline troponin I (A) and T (B) levels: white bars, patients without detectable troponin; shaded bars, patients with moderately elevated troponin I (0.07-1.5 ng/mL) or troponin T (0.04-0.1 ng/mL); solid bars, high troponin levels, defined as >1.5 ng/mL for troponin I and >0.1 ng/mL for troponin T. (Reprinted with permission from ref. 17.)

Mortality Complications Recurrence Mortality Complications Recurrence

Fig. 2. Escalation ofin-hospital mortality, complications, and recurrence rates depending on baseline troponin I (A) and T (B) levels: white bars, patients without detectable troponin; shaded bars, patients with moderately elevated troponin I (0.07-1.5 ng/mL) or troponin T (0.04-0.1 ng/mL); solid bars, high troponin levels, defined as >1.5 ng/mL for troponin I and >0.1 ng/mL for troponin T. (Reprinted with permission from ref. 17.)

Was this article helpful?

0 0

Post a comment